Henry Schein Inc, Melville, NY, announced the completion of the spin-off of its animal health business as the company tightens its focus on growing in its existing dental and medical markets while pursuing new investment opportunities.
According to the company, based on 2017 pro forma sales of approximately $9 billion—excluding the $3.6 billion contribution of the animal health division—the company’s revenue breakdown was $6.1 billion, or 68%, from dental; $2.5 billion, or 28%, from medical; and $338 million, or 4%, from technology and value-added services.
The company’s current suite of offerings includes business, clinical, technology, and supply chain solutions for the dental and medical markets.
